XML 63 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Due To PAVmed Inc. (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Nov. 30, 2022
Oct. 13, 2021
Dec. 31, 2022
Dec. 31, 2021
Apr. 01, 2022
Oct. 05, 2021
Debt Instrument [Line Items]            
Payment obligation         $ 2,100 $ 2,100
Common stock issued for payroll and benefit expense reimbursement, value $ 2,719          
Common stock shares issued for payroll and benefit expense reimbursement 1,479,326          
Related party expense, total     $ 1,649 $ 1,338    
Royalty percentage     5.00%      
Cost of goods and services sold     $ 100,000      
Royalty percentage     8.00%      
Cost of goods and services sold annually     $ 100,000      
Senior Notes [Member]            
Debt Instrument [Line Items]            
Number of debt conversion   15,803,200        
Number of debt conversion value   $ 22,400        
Debt face value   $ 22,400        
Annual interest rate   7.875%        
Debt maturity date   May 18, 2028        
Debt conversion price per share   $ 1.42        
Management Services Agreement [Member]            
Debt Instrument [Line Items]            
Related party expense, total $ 1,650          
Minimum [Member]            
Debt Instrument [Line Items]            
Share price $ 0.40          
Common Stock [Member]            
Debt Instrument [Line Items]            
Issuance of shares 1,145,086          
Common Stock [Member] | Management Services Agreement [Member]            
Debt Instrument [Line Items]            
Number of common shares issued 750,818          
Pavmed Inc [Member]            
Debt Instrument [Line Items]            
Ownership interest           100.00%
Cap Nostics LLC [Member]            
Debt Instrument [Line Items]            
Ownership interest         100.00%